Introduction
The human neurotropic polyomavirus JC (JCV) is the etiological of the fatal CNS demyelinating disease, progressive multifocal leukoencephalopathy, PML (Berger, 2003; Khalili et al., 2006 Khalili et al., , 2008 . While this disease is very rare, the occurrence of JCV infection is common throughout the population worldwide as judged by the high prevalence of antibodies to JCV in human sera (Padgett and Walker, 1973; Walker and Padgett, 1983) . JCV infects most people in childhood and is usually subclinical and asymptomatic, after which the virus is thought to continue to persist in the body in a latent state, where viral protein expression cannot be detected and replication occurs only episodically and at low levels (Hou and Major, 2000; Khalili et al., 2006) . The nature of the latent state is not well understood but it is known that viral DNA can be detected by PCR but expression of the viral proteins is not detectable. Sites where latent JCV has been reported include the kidneys, tonsils, GI tract and brain (reviewed in Del Valle et al., 2008) . Interestingly, the genomic arrangement of the JCV non-coding control region (NCCR) reported in the brain has the hallmark rearrangements typical of strains of JCV isolated from PML, e.g., Mad-1 (Perez-Liz et al., 2008; Elsner and Dorries, 1992; Greenlee et al., 2005; Mori et al., 1991 Mori et al., , 1992 White et al., 1992) . The cells that harbor the latent JCV DNA are the oligodendrocytes and astrocytes but not neurons as determined by laser capture microdissection followed by PCR (Perez-Liz et al., 2008) . On the other hand, it has been argued that the probability that the brain harbors JCV DNA as a functional site of latency may be small and that B lymphoid cells are the real site of functional latency (Major, 2010) . Recently, Tan et al. (2010) demonstrated the presence of JCV DNA in non-PML brain using three different approaches: quantitative PCR, cloning and sequencing of PCR products and in situ hybridization.
In most individuals, JCV replication is either undetectable or occurs episodically at a low level, as evidenced by the intermittent appearance of virus in the urine of normal individuals, and infection is asymptomatic. However in the context of severe immunosuppression, especially AIDS, JCV can be reactivated in the CNS leading to PML. The high incidence of PML in patients infected with HIV-1 makes it an AIDSdefining disease (Holman et al., 1998) . The clinical signs that are observed in patients with PML vary depending on the location of the demyelinated lesions but common symptoms include headaches, limb weakness and cognitive impairments (Berger et al., 1998; Brooks and Walker, 1984) . In PML lesions, expression of the JCV early proteins, e.g., large T-antigen, and late proteins, e.g. VP1 capsid protein, is clearly observable by immunohistochemical labeling in the nuclei of both oligodendrocytes and astrocytes (Del Valle et al., 2008) . Replication of virus occurs in both of these cell types as judged by the presence of virions observed by electron microscopy (Mázló et al., 2001) . Lytic destruction of oligodendrocytes, which produce myelin, is thought to account for the demyelinated phenotype of the PML lesion.
Since the presence of latent PML-type JCV DNA is detectable in the oligodendrocytes and astrocytes of some human brains but viral protein expression is not, it is possible that, in at least some cases of Journal of Neuroimmunology 233 (2011) 46-53 
